Approval · Notice of Compliance 27120 · 2021
FIBRYGA: Notice of Compliance 27120
Issued November 25, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27120
- Date
- November 25, 2021
- Company
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FIBRYGA | Not yet assigned | — |
Medicinal ingredients
- FIBRINOGEN (HUMAN) 1 G per VIAL